Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-24 @ 4:50 PM
NCT ID:
NCT02791750
Eligibility Criteria:
Inclusion Criteria:
* Patients following-up in the Lorraine Institute of Oncology at 5 years of the beginning of an adjuvant hormonal therapy
* Women with breast invasive carcinoma positive-RH and indication of adjuvant hormonal therapy
* Adult patients
* Being capable and agree to follow the study procedure
* Patients informed and non-opposed
* Covered by social security
Exclusion Criteria:
* History of other cancer except basal cell carcinoma
* Patients with breast invasive carcinoma negative-RH
* Synchronous metastases
* Relapsed
* Previous adjuvant hormonal therapy
* Men
* Patients with guardianship
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02791750
Study Brief:
Protocol Section:
NCT02791750